𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A review of compliance to treatment in Alzheimer's disease: potential benefits of a transdermal patch

✍ Scribed by Small, Gary; Dubois, Bruno

Book ID
121398731
Publisher
Informa plc
Year
2007
Tongue
English
Weight
267 KB
Volume
23
Category
Article
ISSN
0300-7995

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rivastigmine transdermal patch and capsu
Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy
✍ Martin R. Farlow; George T. Grossberg; Xiangyi Meng; Jason Olin; Monique Somogyi 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 373 KB

## Abstract ## Objectives The cholinesterase inhibitor rivastigmine is approved for the symptomatic treatment of mild to moderate Alzheimer's disease (AD). This exploratory, hypothesis‐forming analysis assessed response to rivastigmine according to severity of dementia at baseline. ## Methods Th

A six-month double-blind, randomized, pl
A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease–– rivastigmine patch versus capsule
✍ Bengt Winblad; Jeffrey Cummings; Niels Andreasen; George Grossberg; Marco Onofrj 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

## Abstract ## Objectives To compare the efficacy, safety and tolerability of a novel rivastigmine transdermal patch with conventional rivastigmine capsules and placebo in patients with Alzheimer's disease (AD). ## Methods In this 24‐week, multicenter, double‐blind, double‐dummy, placebo‐ and ac